Provided by Tiger Trade Technology Pte. Ltd.

Aura Biosciences, Inc.

7.43
+0.25003.48%
Post-market: 7.430.00000.00%19:51 EDT
Volume:534.54K
Turnover:3.95M
Market Cap:768.16M
PE:-4.19
High:7.52
Open:7.11
Low:7.11
Close:7.18
52wk High:9.54
52wk Low:4.73
Shares:103.39M
Float Shares:79.92M
Volume Ratio:0.84
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7726
EPS(LYR):-1.7599
ROE:-53.49%
ROA:-31.24%
PB:2.44
PE(LYR):-4.22

Loading ...

Aura Biosciences Grants New Executives Stock Options Priced at $7.43, Plus RSUs

Reuters
·
10 hours ago

Aura Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
10 hours ago

Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
10 hours ago

Aura Biosciences Extends Bel-sar Data With Long-Term Follow-Up Study

TIPRANKS
·
Aug 20

Aura Biosciences files $500M mixed securities shelf

TIPRANKS
·
Aug 17

Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Aug 13

Aura Biosciences COO Susan Abu-Absi Files Initial Beneficial Ownership Statement

Reuters
·
Aug 13

Aura Biosciences - May Offer Securities up to $500 Million Aggregate

Reuters
·
Aug 12

Aura Biosciences - May Sell up to $200 Mln Common Stock Under Sales Agreement with Jefferies - SEC Filing

THOMSON REUTERS
·
Aug 12

Aura Biosciences is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 12

Aura Biosciences, Inc. : H.c. Wainwright Cuts Target Price to $18 from $24

THOMSON REUTERS
·
Aug 11

Aura Biosciences Releases Corporate Deck Outlining Bel-Sar Strategy in Ocular Oncology

Reuters
·
Aug 11

Aura Biosciences Q2 Loss Widens

MT Newswires Live
·
Aug 11

Aura Biosciences Q2 EPS $(0.48) Misses $(0.38) Estimate

Benzinga Earnings
·
Aug 11

Earnings Flash (AURA) Aura Biosciences Posts Q2 Net Loss $0.48 a Share, vs. FactSet Est of $0.37 Loss

MT Newswires Live
·
Aug 11

Aura Biosciences, - Phase 3 Compass Trial Fully Enrolled with 108 Patients; Topline Data Expected in 2H 2027

THOMSON REUTERS
·
Aug 11

Aura Biosciences, - Reduces Workforce by About 20% to Focus on Ocular Oncology

THOMSON REUTERS
·
Aug 11

Aura Biosciences, - Organizational Restructuring and Capital Allocation Extend Cash Runway into 1H 2029

THOMSON REUTERS
·
Aug 11

Press Release: Aura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Dow Jones
·
Aug 11

Aura Biosciences Holds Special Shareholder Meeting on Authorized Share Increase Vote

Reuters
·
Aug 06